Starting July 1, Medicare will cover GLP-1 weight loss drugs like Wegovy and Zepbound for $50 monthly. Eligible seniors with obesity can access these treatments under a temporary pilot program through 2027, addressing high costs.
Medicare launches $50 monthly weight-loss drug coverage
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →